21st Jul 2021 11:45
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 20 July 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
357,385 | 10.7300 GBP | 10.7000 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
164,044 | 10.7300 GBP | 10.6994 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
| 3,200 3,923 3,450 112 2,379 4,972 7,619
420 3,596 1,900
9,927 1,824 8,583 4,759 427 2,000 25,473 5
23,283 1,462 33,702 125,000 | 10.7092 GBP 10.7099 GBP 10.7101 GBP 10.7145 GBP 10.7201 GBP 10.7202 GBP 10.7205 GBP
10.7060 GBP 10.7098 GBP 10.7199 GBP
10.6994 GBP 10.7000 GBP 10.7078 GBP 10.7100 GBP 10.7147 GBP 10.7150 GBP 10.7200 GBP 10.7292 GBP
10.7042 GBP 10.7051 GBP 10.7064 GBP 10.7180 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 21 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L